Clinical Trials Browser

Phase 2 × remetinostat × Tumor-Agnostic × Clear all

NCT03875859 2021-05-20

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

Phase 2 Terminated

4 enrolled 9 charts

Carcinoma, Squamous Cell